|
⚲
|
| Keyboard |
| Gallagher Brian M Jr
✚
|
|
|---|---|
| CIK # | 0001709976 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001709976] | |
| 4 | [0001709976] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| eFFECTOR Therapeutics Inc | |
| Gallagher Brian M Jr | |
| Translate Bio Inc | |
| Rein Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2024-06-13 | Grant | 800 | $0.00 | |
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2024-02-19 | Grant | 2,000 | $0.00 | |
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2023-06-22 | Grant | 20,000 | $0.00 | |
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2023-01-20 | Grant | 50,938 | $0.00 | |
|
eFFECTOR Therapeutics Inc EFTR
Common Stock
|
2022-06-23 | Buy | 30,000 | $1.59 | 47,700 |
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2022-06-09 | Grant | 20,000 | $0.00 | |
|
eFFECTOR Therapeutics Inc EFTR
Stock Option (Right to Buy) · derivative
|
2021-10-06 | Grant | 40,000 | $0.00 | |
|
eFFECTOR Therapeutics Inc EFTR
Common Stock
|
2021-08-25 | Grant | 4,822,114 | ||
|
eFFECTOR Therapeutics Inc EFTR
Earn-out Right · derivative
|
2021-08-25 | Grant | 605,338 | $0.00 | |
|
Translate Bio Inc TBIO
Series A Preferred Stock · derivative
|
2018-07-02 | Conversion | 9,300,000 | $0.00 | |
|
Translate Bio Inc TBIO
Common Stock
|
2018-07-02 | Conversion | 1,300,116 | ||
|
Translate Bio Inc TBIO
Common Stock
|
2018-07-02 | Conversion | 454,550 | ||
|
Translate Bio Inc TBIO
Common Stock
|
2018-07-02 | Buy | 269,230 | $13.00 | 3,499,990 |
|
Translate Bio Inc TBIO
Common Stock
|
2018-07-02 | Conversion | 1,674,016 | ||
|
Translate Bio Inc TBIO
Series B Preferred Stock · derivative
|
2018-07-02 | Conversion | 7,222,797 | $0.00 | |
|
Translate Bio Inc TBIO
Series C Preferred Stock · derivative
|
2018-07-02 | Conversion | 2,525,253 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Stock Option (right to buy) · derivative
|
2017-07-25 | Grant | 20,000 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Series E-2 Preferred Stock · derivative
|
2017-07-05 | Conversion | 1,471,551 | $0.00 | |
|
Rein Therapeutics Inc ALRN
Common Stock
|
2017-07-05 | Buy | 273,333 | $15.00 | 4,099,995 |
|
Rein Therapeutics Inc ALRN
Series F Preferred Stock · derivative
|
2017-07-05 | Conversion | 1,979,188 | $0.00 | |
| showing 20 of 23 most recent transactions | |||||